Company Profile

ORRxD is a preclinical drug discovery company specializing in: * Virtual high throughput screening for hit discovery; *A pipeline of investigational new drugs; *Chemogenomic database of chemical compounds that bind to targets in the entire human proteome; ORRxD has developed high expertise in structure-based High Performance Computing (HPC)-driven drug screening and assay development in concert with strong medicinal chemistry and biological validation to support a program in hit discovery, lead optimization and preclinical research up to Investigational New Drug (IND) discovery.